LZTS3/TAGLN Suppresses Cancer Progression in Human Colorectal Adenocarcinoma Through Regulating Cell Proliferation, Migration, and Actin Cytoskeleton
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LZTS3/TAGLN Suppresses Cancer Progression in Human Colorectal Adenocarcinoma Through Regulating Cell Proliferation, Migration, and Actin Cytoskeleton
Authors
Keywords
-
Journal
ARCHIVES OF MEDICAL RESEARCH
Volume 54, Issue 7, Pages 102894
Publisher
Elsevier BV
Online
2023-10-07
DOI
10.1016/j.arcmed.2023.102894
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- β-Trcp and CK1δ-mediated degradation of LZTS2 activates PI3K/AKT signaling to drive tumorigenesis and metastasis in hepatocellular carcinoma
- (2021) Yanwei Lu et al. ONCOGENE
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Long non-coding RNA Lnc-LALC facilitates colorectal cancer liver metastasis via epigenetically silencing LZTS1
- (2021) Chuan Zhang et al. Cell Death & Disease
- ciRS-7 is a prognostic biomarker and potential gene therapy target for renal cell carcinoma
- (2021) Weipu Mao et al. Molecular Cancer
- Transgelin is a poor prognostic factor associated with advanced colorectal cancer (CRC) stage promoting tumor growth and migration in a TGFβ-dependent manner
- (2020) Mona Elsafadi et al. Cell Death & Disease
- Transgelin 2 is required for embryo implantation by promoting actin polymerization
- (2019) Xiaoling Liang et al. FASEB JOURNAL
- Transgelin, a p53 and PTEN-Upregulated Gene, Inhibits the Cell Proliferation and Invasion of Human Bladder Carcinoma Cells in Vitro and in Vivo
- (2019) Tsui et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc
- (2019) Jiayin Tang et al. Nature Communications
- Targeting signalling pathways and the immune microenvironment of cancer stem cells — a clinical update
- (2019) Joseph A. Clara et al. Nature Reviews Clinical Oncology
- LZTS2 inhibits PI3K/AKT activation and radioresistance in nasopharyngeal carcinoma by interacting with p85
- (2018) Shuangbing Xu et al. CANCER LETTERS
- Quantitative Proteomics Identify the Possible Tumor Suppressive Role of Protease-Activated Receptor-4 in Esophageal Squamous Cell Carcinoma Cells
- (2018) Ming Wang et al. PATHOLOGY & ONCOLOGY RESEARCH
- Prosapip1-Dependent Synaptic Adaptations in the Nucleus Accumbens Drive Alcohol Intake, Seeking, and Reward
- (2017) Sophie Laguesse et al. NEURON
- The tumor-suppressor gene LZTS1 suppresses colorectal cancer proliferation through inhibition of the AKT–mTOR signaling pathway
- (2015) Wei Zhou et al. CANCER LETTERS
- Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment
- (2015) E. M. Alexandrova et al. NATURE
- Silencing of Jagged1 inhibits cell growth and invasion in colorectal cancer
- (2014) Y Dai et al. Cell Death & Disease
- MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1
- (2013) Ching-Wen Lin et al. Nature Communications
- MRK003, a γ-secretase inhibitor exhibits promising in vitro pre-clinical activity in multiple myeloma and non-Hodgkin's lymphoma
- (2011) V Ramakrishnan et al. LEUKEMIA
- Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3/p63/Jagged/Notch cascade
- (2010) Jianhui Ma et al. JOURNAL OF CLINICAL INVESTIGATION
- Transgelin as a suppressor is associated with poor prognosis in colorectal carcinoma patients
- (2009) Liang Zhao et al. MODERN PATHOLOGY
- Association of survival and disease progression with chromosomal instability: A genomic exploration of colorectal cancer
- (2009) M. Sheffer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started